Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
rosacea eczema alopecia ceramide keratosis pityriasis basal cell melanoma keratosis purpuraYour Article Summary
Topical treatments for chronic plaque psoriasis
Cochrane Reviews, 04/28/09
Mason AR et al. - Potent corticosteroids were less likely than vitamin D to cause 'local adverse events', such as skin irritation, and people were therefore more likely to stop using vitamin D products. Tazarotene was more likely to cause local adverse events than placebo, and people with psoriasis were therefore more likely to stop using it.
Related Articles
FDA Approves New Drug to Treat Psoriasis
Internet Source, 11/02/09
Relevance Score: 91%
Lack of association between angiotensin I-converting enzyme insertiondeletion polymorphism and psoriasis or psoriatic arthritis in Spain
International Journal of Dermatology, 11/30/09
Relevance Score: 89%
Long-term efalizumab therapy for patients with moderate-to-severe, chronic plaque psoriasis
International Journal of Dermatology, 11/25/09
Relevance Score: 89%
Methotrexate versus traditional Chinese medicine in psoriasis: a randomized, placebo-controlled trial to determine efficacy, safety and quality of life
Clinical and Experimental Dermatology, 11/25/09
Relevance Score: 89%
Scalp psoriasis: European consensus on grading and treatment algorithm
Journal of the European Academy of Dermatology and Venereology, 11/24/09
Relevance Score: 89%
Today in Clinical Pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Low-dose methotrexate treatment for moderate-to-severe atopic dermatitis in adults
Journal of the European Academy of Dermatology and Venereology, 12/17/09
Multiple epidermal cysts occcurring in a tattoo
Singapore Medical Journal, 12/17/09
Efficacy and safety of linezolid in methicillin-resistant Staphylococcus aureus complicated skin and soft tissue infection: a meta-analysis
Current Medical Research and Opinion, 12/17/09
Today in Psoriasis...keeping you current
Receive free subspecialty "5-minute updates" via email
Development and validation of nail psoriasis quality of life scale (NPQ10)
Journal of the European Academy of Dermatology and Venereology, 12/16/09
Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial
Archives of Drug Information, 12/08/09
Analysis of psoriatic patients registered in Asahikawa Medical College Hospital from 1983 to 2007
Journal of Dermatology, 12/08/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


